Canadian DrugGuide Physicians

Trade names-1,400+ monographs

Veröffentlicht von: Skyscape Medpresso

Beschreibung

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
Canadian version 5,000 trade & generic drugs as well as expanded coverage of herbal products. 150 drug classifications. 1200+ Audio pronunciations. 1400+ drug monographs.
Davis’s Canadian Drug Guide for Physicians, delivers all of the information you need to administer medications safely across the lifespan—well-organized monographs for hundreds of generic and thousands of trade-name drugs—along with the Canadian-specific information you want.
NEW IN THIS UPDATE :
* NEW! Added 24 New including adapalene, anacaulase, bempedoic acid/ezetimibe, fostemsavir, naxitamabm, rifamycin, tivozanib, voclosporin, etc.
* NEW! 348 updated Monographs.
- NEW! Added 2 New Indices – BEERS, REMS (Risk Evaluation and Mitigation Strategy).
BONUS!
FREE DIGITAL ACCESS
One-year subscription to Davis’s Canadian Drug Guide for Physicians ® via WebView - Skyscape's online tool. You’ll have access to over 1,400 monographs from your desktop, laptop, or any mobile device with a web browser.
LIFE-SAVING GUIDANCE…AT A GLANCE
Completely updated with expanded coverage on vulnerable populations including:
- New indications and dosing recommendations for top 100 pediatric drugs
- Pediatric, geriatric, and OB medication administration considerations
- A complete immunization schedule
- Special techniques for administering medications to children
- Oral rehydration solutions
- Drugs and breast feeding
- List of drugs associated with increased number of falls in the elderly
More High Alert Coverage and Patient Safety Information than any other drug guide including:
- Special highlights to identify High Alert Medications with high risks for patient injury and information throughout the monograph that explain what the nurse can do to ensure patient safety
- "Do not confuse with" and "Do not crush, break, or chew" caution statements highlighted to support safe practice
- Information on how to prevent administration errors, detect dosing and dispensing errors, and detect or prevent adverse drug reactions (ADR)s.
- Explanations on how to administer medication safely by all routes – including signs and symptoms for toxicity and overdose, safe handling tips and how to educate patients for safe medication use in the home
- No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms.
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $38.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: [email protected] or call 508-299-3000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Author(s): April Hazard Vallerand, PhD, RN, FAAN, Cynthia A. Sanoski, BS, PharmD, FCCP, BCPS
Publisher: F. A. Davis Company
Ausblenden Mehr anzeigen...

In-App-Käufe

15% Off for Limited Period
EGP 1,199.99
20% off for Limited Period
EGP 999.99
25% off for Limited Period
EGP 999.99
CanDrugGuidePhysicians 1/Y Sub
EGP 609.99

Screenshots

Canadian DrugGuide Physicians Häufige Fragen

  • Ist Canadian DrugGuide Physicians kostenlos?

    Ja, Canadian DrugGuide Physicians ist kostenlos herunterzuladen, enthält jedoch In-App-Käufe oder Abonnements.

  • Ist Canadian DrugGuide Physicians seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Canadian DrugGuide Physicians?

    Canadian DrugGuide Physicians bietet mehrere In-App-Käufe/Abonnements, der durchschnittliche In-App-Preis beträgt EGP 652.79.

  • Wie hoch ist der Umsatz von Canadian DrugGuide Physicians?

    Um geschätzte Einnahmen der Canadian DrugGuide Physicians-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Ägypten noch nicht bewertet.
Bewertungsverlauf

Canadian DrugGuide Physicians Bewertungen

Keine Bewertungen in Ägypten
Die App hat noch keine Bewertungen in Ägypten.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
Diagramm
Kategorie
Rang
Top Umsatz
85
Top Kostenlos
160

Canadian DrugGuide Physicians Konkurrenten

Name
ConnectRx
Up-To-Date Drug Reference
Stroke Prevention in AFib
from @Point of Care
AGS GEMS
Davis Lab and Diagnostic Tests
Nursing Implications 9th Ed
Rash
Name the Drug
Biosimilars FDA-based H5O
Pill Identifier and Drug Info
Lets you identify pills & drug
Meds Checker
Clair - Clinical AI Reference

Canadian DrugGuide Physicians Installationen

Letzte 30 Tage

Canadian DrugGuide Physicians Umsatz

Letzte 30 Tage

Canadian DrugGuide Physicians Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Canadian DrugGuide Physicians mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.